The 8th Food Technology Innovation Forum and 2025 Health Food Development Conference was held from April 9th to 10th, bringing together leaders in the industry. Jilin Seno Biotech Co., Ltd., a recognized innovator in health ingredients, was invited to participate and delivered a keynote address on global joint health trends and the emerging role of eggshell membrane applications, attracting widespread interest.

As populations age, health awareness grows, and chronic joint conditions rise, the international market for joint health solutions is experiencing rapid growth. The company’s R&D Director noted that while common ingredients like glucosamine, chondroitin, hyaluronic acid, and type II collagen (UC-II) dominate the market, they face limitations in absorption and efficacy. Eggshell membrane, rich in natural collagen, hyaluronic acid, and chondroitin, is gaining global attention as a next-generation joint health ingredient. Already popular in North America and Europe for functional foods, sports, and pet supplements, its bioactive properties are widely recognized.

In the forum presentation, Jilin Seno Biotech shared insights on leveraging eggshell membrane for innovative product development, combining the latest scientific research, industry trends, and successful case studies. The company highlighted its achievements in targeted enzymatic extraction and screening technology, which earned it the forum’s Technology Innovation Award—recognizing both its technical leadership and its contributions to advancing the industry.

Jilin Seno Biotech’s booth attracted over 500 professional visitors during the event, driving strong interest and engagement. Looking ahead, the company remains committed to innovation-driven growth, aiming to deliver more high-quality and effective joint health ingredients and solutions to consumers worldwide.